ACROBiosystems Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
926
- Stock Symbol
-
301080
- Investments
-
1
- Share Price
-
$12.54
- (As of Friday Closing)
ACROBiosystems General Information
Description
Acrobiosystems Co Ltd is a global brand focusing on protein technology, products and services in the development of biological drugs. It is committed to providing target antigens and other key reagents and related services required in the development of targeted therapeutic drugs.
Contact Information
Website
www.acrobiosystems.comCorporate Office
- 4th Floor, Building 5
- Number 8 Hongda North Road, Beijing Economic and Technological Development Zone
- Beijing
- China
Corporate Office
- 4th Floor, Building 5
- Number 8 Hongda North Road, Beijing Economic and Technological Development Zone
- Beijing
- China
ACROBiosystems Stock Performance
As of 13-Nov-2026, ACROBiosystems’s stock price is $12.54. Its current market cap is $2.1B with 168M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $12.54 | $14.20 | $5.30 - $21.04 | $2.1B | 168M | 16.1M | $0.17 |
ACROBiosystems Financials Summary
As of 30-Sep-2026, ACROBiosystems has a trailing 12-month revenue of $149M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 3,381,838 | 1,031,047 | 484,110 | 723,581 |
| Revenue | 148,821 | 116,546 | 89,893 | 76,843 |
| EBITDA | 24,092 | 26,431 | 16,696 | 21,084 |
| Net Income | 28,251 | 23,023 | 17,258 | 21,710 |
| Total Assets | 470,995 | 430,150 | 399,256 | 396,905 |
| Total Debt | 16,186 | 12,349 | 19,274 | 9,115 |
ACROBiosystems Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ACROBiosystems Comparisons
Industry
Financing
Details
ACROBiosystems Competitors (7)
One of ACROBiosystems’s 7 competitors is CytomX Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Cytovance Biologics | Formerly PE-Backed | Oklahoma City, OK | ||||
| Adcytherix | Venture Capital-Backed | Marseille, France | ||||
| Oxford Biotherapeutics | Private Equity-Backed | Oxford, United Kingdom | ||||
| Mersana Therapeutics | Formerly VC-backed | Cambridge, MA |
ACROBiosystems Patents
ACROBiosystems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021239014-A1 | Anti-sars coronavirus-2 spike protein antibodies | Inactive | 26-May-2020 | ||
| WO-2021213520-A1 | Anti-sars coronavirus-2 spike protein antibodies | Inactive | 24-Apr-2020 | ||
| EP-3976660-A1 | Anti-b7-h3 antibodies | Inactive | 28-May-2019 | ||
| US-20220235134-A1 | Anti-b7-h3 antibodies | Inactive | 28-May-2019 | ||
| WO-2020238926-A1 | Anti-b7-h3 antibodies | Inactive | 28-May-2019 | C07K16/2827 |
ACROBiosystems Signals
ACROBiosystems Investments (1)
ACROBiosystems’s most recent deal was a Early Stage VC with DialBio. The deal was made on 19-Sep-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| DialBio | 19-Sep-2022 | Early Stage VC | Laboratory Services (Healthcare) |
ACROBiosystems ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
ACROBiosystems FAQs
-
When was ACROBiosystems founded?
ACROBiosystems was founded in 2010.
-
Where is ACROBiosystems headquartered?
ACROBiosystems is headquartered in Beijing, China.
-
What is the size of ACROBiosystems?
ACROBiosystems has 926 total employees.
-
What industry is ACROBiosystems in?
ACROBiosystems’s primary industry is Discovery Tools (Healthcare).
-
Is ACROBiosystems a private or public company?
ACROBiosystems is a Public company.
-
What is ACROBiosystems’s stock symbol?
The ticker symbol for ACROBiosystems is 301080.
-
What is the current stock price of ACROBiosystems?
As of 13-Nov-2026 the stock price of ACROBiosystems is $12.54.
-
What is the current market cap of ACROBiosystems?
The current market capitalization of ACROBiosystems is $2.1B.
-
What is ACROBiosystems’s current revenue?
The trailing twelve month revenue for ACROBiosystems is $149M.
-
Who are ACROBiosystems’s competitors?
CytomX Therapeutics, Cytovance Biologics, Adcytherix, Oxford Biotherapeutics, and Mersana Therapeutics are some of the 7 competitors of ACROBiosystems.
-
What is ACROBiosystems’s annual earnings per share (EPS)?
ACROBiosystems’s EPS for 12 months was $0.17.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process